gadolinium dtpa has been researched along with Central Nervous System Diseases in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (10.81) | 18.7374 |
1990's | 26 (70.27) | 18.2507 |
2000's | 7 (18.92) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jacobs, PM; Manninger, SP; Muldoon, LL; Murillo, T; Nesbit, G; Neuwelt, EA | 1 |
Ito, K; Kobayashi, S; Kurihara, K; Nakamura, I; Tanno, M | 1 |
Belahsen, MF; Maaroufi, M; Messouak, O; Sqalli, N; Tizniti, S | 1 |
Anzalone, N; Bowen, BC; Essig, M; Gustafsson, L; Knopp, MV; Kremer, S; Kuhn, MJ; Maldjian, JA; Maravilla, KR; Runge, VM; Schmalfuss, IM; Wippold, FJ; Wolansky, LJ | 1 |
Esparza, J; Hinojosa, J; Muñoz, A | 1 |
Boyer, L; Bruneton, JN; Chanalet, S; Laffont, J; Masson, B | 1 |
Aslanian, V; Borseth, A; Bunouf, P; Lambrechts, M; Lemaignen, H; Lundby, B; Schiratti, M; Svaland, M | 1 |
Akeson, P; Haugen, I; Holtås, S; Jonsson, E | 1 |
Nelson, KL; Runge, VM | 1 |
Kuijpers, TJ; Oudkerk, M; Sijens, PE; Van Beek, EJ | 1 |
Enzmann, DR; Haros, SP; Mehta, RC; Pike, GB | 1 |
Andrew, E; Hugo, F; LaFrance, N; Lundby, B; Svaland, M | 1 |
Baert, AL; Børseth, A; De Greef, D; Demaerel, P; Marchal, G; Van Calenbergh, F; Wilms, G | 1 |
Christensen, T; Lundorf, E; Svaland, MG | 1 |
Berry, I; Brugières, P; de Schepper, AM; Degryse, HR; Gaston, A; Le Bras, F; Manelfe, C; Marsault, C; Parizel, PM; Wichmann, W | 1 |
Beck, W; Haustein, J; Kaiser, W; Laniado, M; Louton, T; Niendorf, HP; Planitzer, J; Reiser, M; Schöffel, M; Schörner, W | 1 |
Aisen, AM; Bradley, WG; Brant-Zawadzki, M; Dreisbach, JN; Haughton, VM; Kumar, AJ; Maravilla, KR; McNamara, MT; Sze, G; Weinreb, JC | 2 |
Ekholm, S; Fagerlund, M; Holtås, S; Isberg, B; Jonsson, E; Lindell, D; Lindén, B; Sandvik, L; Sjöberg, S; Thuomas , KA; Tollesson, PO | 1 |
Aslanian, V; Borseth, A; Bunouf, P; Lemaignen, H; Lundby, B; Svaland, MG | 1 |
Gordon, P; Hugo, F; Lundby, B | 1 |
Ashimine, K; Eto, Y; Maekawa, K; Sugama, S; Yoshimura, H | 1 |
Fukusako, T; Kato, M; Mochizuki, T; Morimatsu, M; Negaro, K; Nogaki, H | 1 |
Doringer, W; Hergan, K; Oser, W | 1 |
Caldemeyer, KS; Greenspan, SL; Lowe, MJ; Mathews, VP; Ulmer, JL; Weber, DM | 1 |
Brunberg, JA; Grodd, W; Grossman, RI; Haughton, VM; Heindel, W; Hunter, G; Jinkins, JR; Kanal, E; Kristy, RM; Kuhn, MJ; Lee, D; Leeds, N; Maravilla, K; Provenzale, JM; Ramsey, R; Rubin, DL; Simon, J; Stevens, GR; Sze, G; Truwit, C; Tu, R; Wippold, FJ; Zelch, J | 1 |
Jinkins, JR; Muroff, LR; Runge, VM | 1 |
Bydder, GM | 1 |
Brant-Zawadzki, M | 1 |
Greco, A; Lanthiez, P; McNamara, MT; Michelozzi, G; Quay, SC | 1 |
Gelblum, DY; Runge, VM | 1 |
Baierl, P; Bauer, WM; Fendel, H; Förster, C; Haustein, J; Mühlsteffen, A; Niendorf, HP | 1 |
Girard, N; Grégoire, N; Lavanga, A; Momose, T; Perot, S; Rumeau, C; Salamon, G | 1 |
Carollo, BR; Gelblum, DY; Nelson, KL; Runge, VM; Wolf, CR | 1 |
Freeman, MW; Kessler, RM; Partain, CL; Powers, TA; Robertson, RH; Whelan, HT; Wyatt, SH | 1 |
Iio, M; Kono, T; Mano, I; Terao, H; Tsuchida, T; Yoshida, H | 1 |
Iio, M | 1 |
6 review(s) available for gadolinium dtpa and Central Nervous System Diseases
Article | Year |
---|---|
Basic principles of MR contrast.
Topics: Central Nervous System Diseases; Contrast Media; Dextrans; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Iron; Magnetic Resonance Imaging; Magnetite Nanoparticles; Organometallic Compounds; Oxides; Pentetic Acid | 1995 |
Central nervous system: review of clinical use of contrast media.
Topics: Central Nervous System Diseases; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Organometallic Compounds | 2001 |
Technical advances in magnetic resonance imaging.
Topics: Central Nervous System; Central Nervous System Diseases; Contrast Media; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1992 |
Pitfalls of contrast-enhanced imaging in the nervous system.
Topics: Central Nervous System Diseases; Central Nervous System Neoplasms; Contrast Media; Costs and Cost Analysis; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1991 |
The role of gadolinium-diethylenetriaminepentaacetic acid in the evaluation of the central nervous system.
Topics: Central Nervous System; Central Nervous System Diseases; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Middle Aged; Organometallic Compounds; Pentetic Acid | 1990 |
Gd DTPA: a review of clinical indications in central nervous system magnetic resonance imaging.
Topics: Brain Neoplasms; Central Nervous System Diseases; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Prospective Studies; Spinal Diseases | 1989 |
19 trial(s) available for gadolinium dtpa and Central Nervous System Diseases
Article | Year |
---|---|
Contrast enhancement of central nervous system lesions: multicenter intraindividual crossover comparative study of two MR contrast agents.
Topics: Central Nervous System Diseases; Contrast Media; Cross-Over Studies; Double-Blind Method; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies; Statistics, Nonparametric | 2006 |
Cisternography and ventriculography gadopentate dimeglumine-enhanced MR imaging in pediatric patients: preliminary report.
Topics: Adolescent; Arachnoiditis; Brain Neoplasms; Central Nervous System Diseases; Cerebral Ventriculography; Child; Child, Preschool; Contrast Media; Female; Gadolinium DTPA; Humans; Hydrocephalus; Infant; Infant, Newborn; Injections, Spinal; Magnetic Resonance Imaging; Male; Meningomyelocele; Myelography; Pilot Projects; Skull Fractures; Subarachnoid Space | 2007 |
[Comparative studies of the tolerability of gadodiamide, dimeglumine gadopentetate and meglumine gadoterate in MRI tests of the central nervous system].
Topics: Adult; Central Nervous System Diseases; Contrast Media; Double-Blind Method; Drug Combinations; Drug Hypersensitivity; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Risk Factors | 1995 |
[Clinical evaluation of the tolerability of gadodiamide, a new nonionic contrast agent in MRI of the central nervous system].
Topics: Adult; Aged; Aged, 80 and over; Central Nervous System Diseases; Contrast Media; Female; Gadolinium DTPA; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid | 1995 |
Contrast-enhanced MRI of the central nervous system: comparison between gadodiamide injection and gadolinium-DTPA.
Topics: Central Nervous System Diseases; Contrast Media; Double-Blind Method; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid | 1995 |
Safety and efficacy of dotarem (Gd-DOTA) versus magnevist (Gd-DTPA) in magnetic resonance imaging of the central nervous system.
Topics: Adult; Aged; Central Nervous System; Central Nervous System Diseases; Chi-Square Distribution; Contrast Media; Double-Blind Method; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid | 1995 |
Clinical experience with gadodiamide injection in magnetic resonance imaging of the central nervous system.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Central Nervous System Diseases; Contrast Media; Double-Blind Method; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid | 1994 |
Gadodiamide injection at 0.1 and 0.3 mmol/kg body weight: a phase III double-blind, parallel, randomised clinical investigation of known or suspected central nervous system lesions at 1.5 T.
Topics: Central Nervous System Diseases; Contrast Media; Double-Blind Method; Female; Gadolinium DTPA; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid | 1994 |
Comparison of the safety of standard and triple dose gadodiamide injection in MR imaging of the central nervous system. A double-blind study.
Topics: Adult; Aged; Bilirubin; Blood Pressure; Central Nervous System Diseases; Contrast Media; Double-Blind Method; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid; Safety; Spinal Cord Diseases | 1994 |
Randomised double blind trial of the safety and efficacy of two gadolinium complexes (Gd-DTPA and Gd-DOTA).
Topics: Adult; Central Nervous System Diseases; Contrast Media; Double-Blind Method; Female; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid | 1994 |
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid | 1993 |
Use of the magnetic resonance contrast agent gadodiamide in the central nervous system. Results of a multicenter trial.
Topics: Central Nervous System Diseases; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid | 1993 |
Tolerance and efficacy of Omniscan (gadodiamide injection) in MR imaging of the central nervous system.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Central Nervous System Diseases; Contrast Media; Drug Tolerance; Female; Gadolinium; Gadolinium DTPA; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid; Surveys and Questionnaires | 1996 |
Evaluation of the clinical safety of gadodiamide injection, a new nonionic MRI contrast medium for the central nervous system: a European perspective.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Central Nervous System Diseases; Contrast Media; Europe; Female; Gadolinium DTPA; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid | 1996 |
MRI in children given gadodiamide injection: safety and efficacy in CNS and body indications.
Topics: Adolescent; Central Nervous System Diseases; Child; Child, Preschool; Clinical Trials, Phase III as Topic; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Infant; Infant, Newborn; Magnetic Resonance Imaging; Meglumine; Multicenter Studies as Topic; Organometallic Compounds; Pentetic Acid; Randomized Controlled Trials as Topic; Safety | 1996 |
Magnetic resonance imaging in patients with central nervous system pathology: a comparison of OptiMARK (Gd-DTPA-BMEA) and Magnevist (Gd-DTPA).
Topics: Adult; Aged; Brain; Central Nervous System Diseases; Contrast Media; Double-Blind Method; Female; Gadolinium; Gadolinium DTPA; Humans; Male; Middle Aged; Organometallic Compounds; Spinal Cord | 2000 |
Multicenter study of gadodiamide injection as a contrast agent in MR imaging of the brain and spine.
Topics: Brain; Central Nervous System Diseases; Contrast Media; Drug Evaluation; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid; Spinal Cord | 1991 |
Gadodiamide injection: nonionic gadolinium chelate for MR imaging of the brain and spine--phase II-III clinical trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain; Brain Neoplasms; Central Nervous System Diseases; Cerebrovascular Disorders; Clinical Trials as Topic; Female; Gadolinium DTPA; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid; Spinal Cord Neoplasms; Spine | 1990 |
Central nervous system lesions in pediatric patients: Gd-DTPA-enhanced MR imaging.
Topics: Adolescent; Astrocytoma; Brain Neoplasms; Central Nervous System Diseases; Child; Child, Preschool; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Medulloblastoma; Multicenter Studies as Topic; Organometallic Compounds; Pentetic Acid | 1988 |
12 other study(ies) available for gadolinium dtpa and Central Nervous System Diseases
Article | Year |
---|---|
An exploratory study of ferumoxtran-10 nanoparticles as a blood-brain barrier imaging agent targeting phagocytic cells in CNS inflammatory lesions.
Topics: Adolescent; Adult; Aged; Blood-Brain Barrier; Brain; Brain Neoplasms; Central Nervous System Diseases; Cerebrovascular Disorders; Contrast Media; Demyelinating Diseases; Dextrans; Female; Ferrosoferric Oxide; Gadolinium DTPA; Humans; Inflammation; Iron; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Nanostructures; Oxides; Phagocytes | 2005 |
New-onset demyelination induced by infliximab therapy in two rheumatoid arthritis patients.
Topics: Aged; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Central Nervous System Diseases; Contrast Media; Demyelinating Diseases; Female; Gadolinium DTPA; Humans; Infliximab; Magnetic Resonance Imaging; Male; Middle Aged; Steroids; Tumor Necrosis Factor-alpha | 2006 |
[Spinal tuberculous arachnoiditis with intradural extramedullary tuberculomas].
Topics: Adult; Arachnoiditis; Central Nervous System Diseases; Contrast Media; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Tuberculoma; Tuberculosis, Meningeal; Tuberculosis, Spinal | 2006 |
Central nervous system tumor, infection, and infarction: detection with gadolinium-enhanced magnetization transfer MR imaging.
Topics: Adult; Aged; Brain; Brain Neoplasms; Central Nervous System Diseases; Cerebral Infarction; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Prospective Studies | 1995 |
Enhanced magnetic resonance imaging of leptomeningeal angiomatosis.
Topics: Angiomatosis; Central Nervous System Diseases; Child; Child, Preschool; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meninges; Tomography, X-Ray Computed | 1997 |
[Magnetic resonance imaging of a case of central nervous system tuberculosis with tuberculous arachnoiditis and multiple tuberculomas].
Topics: Arachnoiditis; Central Nervous System Diseases; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Middle Aged; Tuberculoma; Tuberculosis; Tuberculosis, Meningeal | 1997 |
[Contrast-enhanced subtraction MRT in the spin-echo technic].
Topics: Adolescent; Adult; Aged; Central Nervous System Diseases; Child; Child, Preschool; Contrast Media; Evaluation Studies as Topic; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Musculoskeletal Diseases; Retrospective Studies; Subtraction Technique | 1998 |
Brain: gadolinium-enhanced fast fluid-attenuated inversion-recovery MR imaging.
Topics: Brain; Brain Diseases; Central Nervous System Diseases; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Phantoms, Imaging | 1999 |
Comparison of plain and Gd-DTPA-enhanced MR-imaging in children.
Topics: Adolescent; Brain Neoplasms; Central Nervous System Diseases; Child; Child, Preschool; Female; Gadolinium; Gadolinium DTPA; Humans; Infant; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Spinal Cord Neoplasms | 1990 |
[Gadolinium-DTPA in the study of intracranial tumors in the adult].
Topics: Adult; Aged; Brain Neoplasms; Central Nervous System Diseases; Female; Gadolinium DTPA; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organometallic Compounds; Pentetic Acid | 1990 |
[The enhancement effects of Gd-DTPA for cerebrospinal lesions-- comparison with conventional T2-weighted images].
Topics: Central Nervous System Diseases; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid | 1987 |
[Contrast-enhanced MRI and contrast medium development].
Topics: Central Nervous System Diseases; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Spectroscopy; Organometallic Compounds; Pentetic Acid | 1987 |